Related Experiment Video
Updated: Jul 7, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure
Filippe Barcellos Filippini1,2, Henrique Barbosa Ribeiro1,3, Edimar Bocchi1
1Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo , São Paulo , SP - Brasil.
Arquivos Brasileiros De Cardiologia
|December 21, 2023
Summary
New transcatheter devices offer innovative monitoring and treatment for chronic heart failure patients. These minimally invasive tools are transforming cardiac insufficiency care, focusing on advanced therapeutic strategies.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Cardiology
Background:
- Recent innovations in cardiac devices have improved diagnosis and treatment for heart failure.
- Minimally invasive strategies are increasingly adopted for cardiac insufficiency management.
- Focus on device-based diagnosis and treatment for chronic heart failure.
Purpose of the Study:
- To review current and future device-based diagnostic and therapeutic strategies for chronic heart failure.
- To highlight percutaneous approaches for managing advanced heart failure patients.
Main Methods:
- Review of recent advancements in transcatheter devices for heart failure.
- Discussion of device applications in monitoring and treatment.
- Exploration of minimally invasive techniques.
Main Results:
- Transcatheter devices offer new avenues for monitoring and treating chronic heart failure.
- Minimally invasive approaches are becoming standard in cardiac care.
- Innovations focus on advanced patient management.
Conclusions:
- Device innovation is crucial for advancing chronic heart failure management.
- Percutaneous strategies represent a significant shift in treating cardiac insufficiency.
- Future directions involve integrated device-based therapeutic systems.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:22Heart Failure Drugs: Diuretics
394
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
394
01:24Cardiac Catheterization III: Left Heart Catheterization
15
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
15
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K